Role of Vitamin D in Cardiovascular Health

DeLuca, 2004, Overview of general physiologic features and functions of vitamin D, Am J Clin Nutr, 80, 1689S, 10.1093/ajcn/80.6.1689S Nibbelink, 2007, 1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte, J Steroid Biochem Mol Biol, 103, 533, 10.1016/j.jsbmb.2006.12.099 Pilz, 2009, Vitamin D status and arterial hypertension: a systematic review, Nat Rev Cardiol, 6, 621, 10.1038/nrcardio.2009.135 Vieth, 1999, Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety, Am J Clin Nutr, 69, 842, 10.1093/ajcn/69.5.842 Calvo, 2004, Vitamin D fortification in the United States and Canada: current status and data needs, Am J Clin Nutr, 80, 1710S, 10.1093/ajcn/80.6.1710S Kim, 2008, Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004), Am J Cardiol, 102, 1540, 10.1016/j.amjcard.2008.06.067 Holick, 2007, Vitamin D deficiency, N Engl J Med, 357, 266, 10.1056/NEJMra070553 Lee, 2008, Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?, J Am Coll Cardiol, 52, 1949, 10.1016/j.jacc.2008.08.050 Tangpricha, 2002, Vitamin D insufficiency among free-living healthy young adults, Am J Med, 112, 659, 10.1016/S0002-9343(02)01091-4 Harris, 2000, Vitamin D insufficiency and hyperparathyroidism in a low income, multiracial, elderly population, J Clin Endocrinol Metab, 85, 4125 Looker, 2002, Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III, Bone, 30, 771, 10.1016/S8756-3282(02)00692-0 Heaney, 2003, Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol, Am J Clin Nutr, 77, 204, 10.1093/ajcn/77.1.204 Holick, 2008, Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D, J Clin Endocrinol Metab, 93, 677, 10.1210/jc.2007-2308 Bischoff-Ferrari, 2006, Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes, Am J Clin Nutr, 84, 18, 10.1093/ajcn/84.1.18 Hall, 2010, Vitamin D intake needed to maintain target serum 25-hydroxyvitamin D concentrations in participants with low sun exposure and dark skin pigmentation is substantially higher than current recommendations, J Nutr, 140, 542, 10.3945/jn.109.115253 Stechschulte, 2009, Vitamin D: bone and beyond, rationale and recommendations for supplementation, Am J Med, 122, 793, 10.1016/j.amjmed.2009.02.029 Hathcock, 2007, Risk assessment for vitamin D, Am J Clin Nutr, 85, 6, 10.1093/ajcn/85.1.6 Stephenson, 2009, The lack of vitamin D toxicity with megadose of daily ergocalciferol (D2) therapy: a case report and literature review, South Med J, 102, 765, 10.1097/SMJ.0b013e3181a8d1e4 Kimball, 2008, Self-prescribed high-dose vitamin D3: effects on biochemical parameters in two men, Ann Clin Biochem, 45, 106, 10.1258/acb.2007.007074 Resnick, 1986, Calcium-regulating hormones in essential hypertension, Ann Intern Med, 105, 649, 10.7326/0003-4819-105-5-649 Li, 2002, 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system, J Clin Invest, 110, 229, 10.1172/JCI0215219 Krause, 1998, Ultraviolet B and blood pressure, Lancet, 352, 709, 10.1016/S0140-6736(05)60827-6 Burgess, 1990, Interaction of 1,25-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension, Am J Hypertens, 3, 903, 10.1093/ajh/3.12.903 Tarcin, 2009, Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects, J Clin Endocrinol Metab, 94, 4023, 10.1210/jc.2008-1212 Duprez, 1994, Relationship between vitamin D3 and the peripheral circulation in moderate arterial primary hypertension, Blood Press, 3, 389, 10.3109/08037059409102292 Kristal-Boneh, 1997, Association of calcitriol and blood pressure in normotensive men, Hypertension, 30, 1289, 10.1161/01.HYP.30.5.1289 Scragg, 1995, Serum 25-hydroxycholecalciferol concentration in newly detected hypertension, Am J Hypertens, 8, 429, 10.1016/0895-7061(94)00195-H Scragg, 2007, Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey, Am J Hypertens, 20, 713, 10.1016/j.amjhyper.2007.01.017 Sugden, 2008, Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels, Diabet Med, 25, 320, 10.1111/j.1464-5491.2007.02360.x Pfeifer, 2001, Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women, J Clin Endocrinol Metab, 86, 1633 Witham, 2009, Effect of vitamin D on blood pressure: a systematic review and meta-analysis, J Hypertens, 27, 1948, 10.1097/HJH.0b013e32832f075b Melamed, 2008, Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004, Arterioscler Thromb Vasc Biol, 28, 1179, 10.1161/ATVBAHA.108.165886 Targher, 2006, Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients, Clin Endocrinol (Oxf), 65, 593, 10.1111/j.1365-2265.2006.02633.x Reis, 2008, Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease, Am J Clin Nutr, 88, 1469, 10.3945/ajcn.2008.26447 Fahrleitner, 2002, Vitamin D deficiency and secondary hyperparathyroidism are common complications in patients with peripheral arterial disease, J Gen Intern Med, 17, 663, 10.1046/j.1525-1497.2002.11033.x Pittas, 2007, The role of vitamin D and calcium in type 2 diabetes, J Clin Endocrinol Metab, 92, 2017, 10.1210/jc.2007-0298 Bland, 2004, Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets, J Steroid Biochem Mol Biol, 89 Zeitz, 2003, Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor, FASEB J, 17, 509, 10.1096/fj.02-0424fje Bourlon, 1999, The de novo synthesis of numerous proteins is decreased during vitamin D3 deficiency and is gradually restored by 1, 25-dihydroxyvitamin D3 repletion in the islets of Langerhans of rats, J Endocrinol, 162, 101, 10.1677/joe.0.1620101 Maestro, 2000, Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells, Endocr J, 47, 383, 10.1507/endocrj.47.383 Karvonen, 1998, Comparison of the seasonal pattern in the clinical onset of IDDM in Finland and Sardinia, Diabetes Care, 21, 1101, 10.2337/diacare.21.7.1101 Mohr, 2008, The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide, Diabetologia, 51, 1391, 10.1007/s00125-008-1061-5 1999, Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus, Diabetologia, 42, 51, 10.1007/s001250051112 Ishii, 2001, Seasonal variation of glycemic control in type 2 diabetic patients, Diabetes Care, 24, 1503, 10.2337/diacare.24.8.1503 Borissova, 2003, The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients, Int J Clin Pract, 57, 258, 10.1111/j.1742-1241.2003.tb10480.x Chiu, 2004, Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction, Am J Clin Nutr, 79, 820, 10.1093/ajcn/79.5.820 Schwalfenberg, 2008, Vitamin D and diabetes: improvement of glycemic control with vitamin D3 repletion, Can Fam Physician, 54, 864 Martini, 2006, Vitamin D status and the metabolic syndrome, Nutr Rev, 64, 479, 10.1111/j.1753-4887.2006.tb00180.x Fliser, 1997, No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects, Eur J Clin Invest, 27, 629, 10.1046/j.1365-2362.1997.1520699.x Tai, 2008, Glucose tolerance and vitamin D: effects of treating vitamin D deficiency, Nutrition, 24, 950, 10.1016/j.nut.2008.04.009 Dilmec, 2009, Detection of VDR gene ApaI and TaqI polymorphisms in patients with type 2 diabetes mellitus using PCR-RFLP method in a Turkish population, J Diabetes Complications, 24, 186, 10.1016/j.jdiacomp.2008.12.002 Malecki, 2003, Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population, Exp Clin Endocrinol Diabetes, 111, 505, 10.1055/s-2003-44711 Bid, 2009, Vitamin D receptor (FokI, BsmI and TaqI) gene polymorphisms and type 2 diabetes mellitus: a North Indian study, Indian J Med Sci, 63, 187, 10.4103/0019-5359.53164 Danescu, 2009, Vitamin D and diabetes mellitus, Endocrine, 35, 11, 10.1007/s12020-008-9115-5 Lind, 1995, Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men, Am J Hypertens, 8, 894, 10.1016/0895-7061(95)00154-H Heikkinen, 1997, Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy, Eur J Endocrinol, 137, 495, 10.1530/eje.0.1370495 Montagnani, 1994, Effects of pravastatin treatment on vitamin D metabolites, Clin Ther, 16, 824 Perez-Castrillon, 2007, Effects of atorvastatin on vitamin D levels in patients with acute ischemic heart disease, Am J Cardiol, 99, 903, 10.1016/j.amjcard.2006.11.036 Wilczek, 1994, Monitoring plasma levels of vitamin D metabolites in simvastatin (Zocor) therapy in patients with familial hypercholesterolemia [article in Czech], Cas Lek Cesk, 133, 727 Yavuz, 2009, Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins?, Cardiovasc Drugs Ther, 23, 295, 10.1007/s10557-009-6181-8 Guryev, 2003, A pathway for the metabolism of vitamin D3: unique hydroxylated metabolites formed during catalysis with cytochrome P450scc (CYP11A1), Proc Natl Acad Sci U S A, 100, 14754, 10.1073/pnas.2336107100 Oh, 2009, 1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus, Circulation, 120, 687, 10.1161/CIRCULATIONAHA.109.856070 Zittermann, 2007, Patients with congestive heart failure and healthy controls differ in vitamin D-associated lifestyle factors, Int J Vitam Nutr Res, 77, 280, 10.1024/0300-9831.77.4.280 Watson, 1997, Active serum vitamin D levels are inversely correlated with coronary calcification, Circulation, 96, 1755, 10.1161/01.CIR.96.6.1755 Fleck, 1989, Latitude and ischaemic heart disease, Lancet, 1, 613, 10.1016/S0140-6736(89)91634-6 Kendrick, 2009, 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey, Atherosclerosis, 205, 255, 10.1016/j.atherosclerosis.2008.10.033 Melamed, 2008, 25-hydroxyvitamin D levels and the risk of mortality in the general population, Arch Intern Med, 168, 1629, 10.1001/archinte.168.15.1629 Wolf, 2007, Vitamin D levels and early mortality among incident hemodialysis patients, Kidney Int, 72, 1004, 10.1038/sj.ki.5002451 Giovannucci, 2008, 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study, Arch Intern Med, 168, 1174, 10.1001/archinte.168.11.1174 Wang, 2008, Vitamin D deficiency and risk of cardiovascular disease, Circulation, 117, 503, 10.1161/CIRCULATIONAHA.107.706127 Pilz, 2008, Low vitamin d levels predict stroke in patients referred to coronary angiography, Stroke, 39, 2611, 10.1161/STROKEAHA.107.513655 Pilz, 2008, Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography, J Clin Endocrinol Metab, 93, 3927, 10.1210/jc.2008-0784 LaCroix, 2009, Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial, J Gerontol A Biol Sci Med Sci, 64, 559, 10.1093/gerona/glp006 Trivedi, 2003, Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial, BMJ, 326, 469, 10.1136/bmj.326.7387.469 Tishkoff, 2008, Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility, Endocrinology, 149, 558, 10.1210/en.2007-0805 Weishaar, 1990, Involvement of vitamin D3 with cardiovascular function, Am J Physiol, 258, E134 Szabó, 2009, The role of vitamin D in the development of cardiac failure [article in Hungarian], Orv Hetil, 150, 1397, 10.1556/OH.2009.28674 McGonigle, 1984, Uremic cardiomyopathy: potential role of vitamin D and parathyroid hormone, Nephron, 36, 94, 10.1159/000183125 Shane, 1997, Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure, Am J Med, 103, 197, 10.1016/S0002-9343(97)00142-3 Bahrami, 2008, Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis, Arch Intern Med, 168, 2138, 10.1001/archinte.168.19.2138 Laguardia, 2006, Secondary hyperparathyroidism and hypovitaminosis D in African-Americans with decompensated heart failure, Am J Med Sci, 332, 112, 10.1097/00000441-200609000-00003 Coughlin, 1997, What explains black-white differences in survival in idiopathic dilated cardiomyopathy?, J Natl Med Assoc, 89, 277 Dries, 1999, Racial differences in the outcome of left ventricular dysfunction, N Engl J Med, 340, 609, 10.1056/NEJM199902253400804 Vaccarino, 2002, Differences between African Americans and whites in the outcome of heart failure: Evidence for a greater functional decline in African Americans, Am Heart J, 143, 1058, 10.1067/mhj.2002.122123 Reusser, 2003, Adequate nutrient intake can reduce cardiovascular disease risk in African Americans, J Natl Med Assoc, 95, 188 Hagstrom, 2009, Plasma parathyroid hormone and the risk of cardiovascular mortality in the community, Circulation, 119, 2765, 10.1161/CIRCULATIONAHA.108.808733 Luboshitzky, 2009, Cardiovascular risk factors in primary hyperparathyroidism, J Endocrinol Invest, 32, 317, 10.1007/BF03345719 Yu N, T PD, Flynn Robert WV, Michael JM, Smith D, Rudman A, Graham PL. Increased mortality and morbidity in mild primary hyperparathyroid patients. Clin Endocrinol (Oxf). In press. Bell, 1985, Evidence for alteration of the vitamin D-endocrine system in obese subjects, J Clin Invest, 76, 370, 10.1172/JCI111971 Alsafwah, 2008, Hypovitaminosis D in African Americans residing in Memphis, Tennessee with and without heart failure, Am J Med Sci, 335, 292, 10.1097/MAJ.0b013e318167b0bd Nesby-O'Dell, 2002, Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: Third National Health and Nutrition Examination Survey, 1988–1994, Am J Clin Nutr, 76, 187, 10.1093/ajcn/76.1.187 Wolf, 2008, Impact of activated vitamin D and race on survival among hemodialysis patients, J Am Soc Nephrol, 19, 1379, 10.1681/ASN.2007091002 Zittermann, 2008, Poor outcome in end-stage heart failure patients with low circulating calcitriol levels, Eur J Heart Fail, 10, 321, 10.1016/j.ejheart.2008.01.013 Testa, 2009, Vitamin D receptor (VDR) gene polymorphism is associated with left ventricular (LV) mass and predicts LVH progression in end stage renal disease (ESRD) patients, J Bone Miner Res, 25, 313, 10.1359/jbmr.090717 Park, 1999, Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism, Am J Kidney Dis, 33, 73, 10.1016/S0272-6386(99)70260-X Schleithoff, 2006, Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial, Am J Clin Nutr, 83, 754, 10.1093/ajcn/83.4.754 Chavan, 2007, Hypocalcemia as a cause of reversible cardiomyopathy with ventricular tachycardia, Ann Intern Med, 146, 541, 10.7326/0003-4819-146-7-200704030-00020 Vintzileos, 1985, Three fetal ponderal indexes in normal pregnancy, Obstet Gynecol, 65, 807 Sood, 1995, Effect of vitamin D deficiency on electrocardiogram of rats, Indian J Exp Biol, 33, 61 Autier, 2007, Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials, Arch Intern Med, 167, 1730, 10.1001/archinte.167.16.1730